Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells

The active form of vitamin D, 1α,25-dihydroxyvitamin D 3 (1,25D), has a broad range of effects which are mediated by nuclear vitamin D receptor (VDR). Many experiments that investigate the role of VDR can be done in human acute myeloid leukemia (AML) cells, since these cells are responsive to 1,25D...

Full description

Saved in:
Bibliographic Details
Published inJournal of steroid biochemistry and molecular biology Vol. 121; no. 1; pp. 114 - 116
Main Authors Marcinkowska, Ewa, Gocek, Elżbieta
Format Journal Article Conference Proceeding
LanguageEnglish
Published Kidlington Elsevier Ltd 01.07.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The active form of vitamin D, 1α,25-dihydroxyvitamin D 3 (1,25D), has a broad range of effects which are mediated by nuclear vitamin D receptor (VDR). Many experiments that investigate the role of VDR can be done in human acute myeloid leukemia (AML) cells, since these cells are responsive to 1,25D and express VDR in a 1,25D-regulated manner. In this paper we show that in HL60 and in THP-1 cells VDR protein interacts with heat shock protein 90 (Hsp90) and that Hsp90 is important for differentiation of AML cells. Geldanamycin (GA), an Hsp90 inhibitor, is able to suppress 1,25-induced differentiation of HL60 cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-0760
1879-1220
DOI:10.1016/j.jsbmb.2010.01.013